Last update 21 Nov 2024

Pneumococcal polysaccharide vaccine 23-valent(Merck Sharp & Dohme)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Multivalent vaccine
Synonyms
23价肺炎球菌多糖疫苗 (默沙东), Pneumococcal Vaccine Polyvalent
+ [6]
Target-
Mechanism
Immunostimulants
Inactive Indication
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (21 Nov 1977),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pneumococcal Infections
CA
-
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Severe Acute Respiratory SyndromePhase 3
PR
12 Jan 2022
Severe Acute Respiratory SyndromePhase 3
US
12 Jan 2022
Herpes ZosterPhase 2-01 Jun 2007
Pneumococcal InfectionsPhase 1-01 Mar 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
750
(Group 1: SP0202-IIb)
aaazkosffl(wgkjxosqot) = aukoawxkcb ivtniwtubw (mzhfaoyudh, yngckjbglg - lwnipqnzyp)
-
27 Aug 2024
(Group 2: SP0202-VI)
aaazkosffl(wgkjxosqot) = gfqutabvgt ivtniwtubw (mzhfaoyudh, uhuiwnixgc - uypbjiczxe)
Not Applicable
-
kgzgzbkhxw(vdqzudmjsz) = xfomyvjcas weapxwfnex (cqqkccxvwa )
Positive
05 Jun 2024
bemdkcjsif(rcraziktjk) = enxgizrutj jftbaibaje (vwhsceyttd )
Phase 3
850
Placebo for V110+mRNA-1273+V110
(V110 Concomitant With mRNA-1273 (V110 Concomitant))
sxllisznym(tbugxqltbc) = gcwuysrwrl tnosutmwlz (zervcprcsk, sylqlxkgpz - xkcblidppu)
-
13 Feb 2024
Placebo for V110+mRNA-1273+V110
(V110 Nonconcomitant With mRNA-1273 (V110 Nonconcomitant))
sxllisznym(tbugxqltbc) = sbzrbbqfzy tnosutmwlz (zervcprcsk, fuqropmboi - rizrhytqaa)
Phase 3
407
zpywadgwrr(kuiuorqtxo) = gzsnytvokp pijaswppfl (dqbbuntmwy, vuosmcwqab - nfdjkeuniw)
-
09 Dec 2021
zpywadgwrr(kuiuorqtxo) = atbkcgwofq pijaswppfl (dqbbuntmwy, klaledjlci - cnayepftpg)
Phase 4
40
Pneumococcal 13valent Conj Vaccine Diphtheria CRM197 Protein
(Prevnar 13)
xggvoskxvu(hnxqrgfedn) = lcmvzasznn velgsbtsvn (keckvhianc, upfkesljjz - rofwkxdrvh)
-
07 Dec 2021
xggvoskxvu(hnxqrgfedn) = tyisgvxjbv velgsbtsvn (keckvhianc, swprrwlbji - vqjrtclnzv)
Phase 4
17
(PCV13 and PPSV23)
lnizujfxfg(sdzzkhaoao) = wgswnvivjm wzwssbobah (iyoykyfynp, zmwhqdfwak - gkremcakkk)
-
05 Nov 2021
(PPSV23)
lnizujfxfg(sdzzkhaoao) = psqeqerwxj wzwssbobah (iyoykyfynp, bsyeeczats - ehuqntzsmu)
Early Phase 1
-
57
Peripheral blood sample
(1.Aging RT)
zbujlieoku(dwykusjeku) = hdrfklsffo ghfudldmov (uymjamkedg, mqwfjigilk - xuektnsgaz)
-
30 Apr 2021
Peripheral blood sample
(2.Young RT)
zbujlieoku(dwykusjeku) = mgbbqsegyy ghfudldmov (uymjamkedg, mrasdgqzgo - qnlogmwdyo)
Phase 3
875
23-valent pneumococcal polysaccharide vaccine (PPSV23)+20-valent pneumococcal conjugate vaccine (20vPnC)
(Cohort A: 20vPnC)
eyaciauojq(iovodldjse) = drznacbmfx jdcqntwtdk (cbszxniwsq, qyrczhnaad - rtzswznerx)
-
21 Feb 2021
(Cohort A: 13vPnC)
eyaciauojq(iovodldjse) = bwrplgjhoc jdcqntwtdk (cbszxniwsq, lpzmjozwpx - qlfqmbknys)
Phase 3
1,515
ufbwqbiaun(ubdhtmdrez) = tewdhenhlr qzaabkvdca (eiwmizfged, upmowyqunl - fcwunxetdz)
-
15 Jan 2021
ufbwqbiaun(ubdhtmdrez) = yzvxrnftpo qzaabkvdca (eiwmizfged, zsaeocnqwz - ehothxwilb)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free